These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes. Trofe-Clark J, Reese PP, Patel HJ, Jakobowski D, Goral S, Doll SL, Abt PL, Bloom RD. Transplantation; 2012 Sep 15; 94(5):506-12. PubMed ID: 22895613 [Abstract] [Full Text] [Related]
3. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients. Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC. Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460 [Abstract] [Full Text] [Related]
4. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin. Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA. Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977 [Abstract] [Full Text] [Related]
5. Deep vein thrombosis during rabbit antithymocyte globulin administration. Mathis AS, Rao V. Transplant Proc; 2004 Dec 27; 36(10):3250-1. PubMed ID: 15686740 [Abstract] [Full Text] [Related]
6. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age. Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT, Krauss AG, Mannan S, Nezakatgoo N, Osama Gaber A. Clin Transplant; 2011 Dec 27; 25(3):E250-6. PubMed ID: 21231963 [Abstract] [Full Text] [Related]
7. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection. Deeks ED, Keating GM. Drugs; 2009 Jul 30; 69(11):1483-512. PubMed ID: 19634926 [Abstract] [Full Text] [Related]
8. Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal. Tsapepas DS, Mohan S, Tanriover B, Dube G, Crew RJ, Cohen DJ, Hardy MA, Sandoval PR, Ratner LE. Transplantation; 2012 Aug 27; 94(4):325-30. PubMed ID: 22814328 [Abstract] [Full Text] [Related]
9. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection. Khosroshahi HT, Tubbs RS, Shoja MM, Ghafari A, Noshad H, Ardalan MR. Transplant Proc; 2008 Aug 27; 40(1):137-9. PubMed ID: 18261569 [Abstract] [Full Text] [Related]
10. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Stevens RB, Mercer DF, Grant WJ, Freifeld AG, Lane JT, Groggel GC, Rigley TH, Nielsen KJ, Henning ME, Skorupa JY, Skorupa AJ, Christensen KA, Sandoz JP, Kellogg AM, Langnas AN, Wrenshall LE. Transplantation; 2008 May 27; 85(10):1391-9. PubMed ID: 18497677 [Abstract] [Full Text] [Related]
11. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation. Kamel MH, Mohan P, Little DM, Awan A, Hickey DP. J Urol; 2005 Aug 27; 174(2):703-7. PubMed ID: 16006954 [Abstract] [Full Text] [Related]
12. Analysis of infusion-site reactions in renal transplant recipients receiving peripherally administered rabbit antithymocyte globulin as compared with basiliximab. Erickson AL, Roberts K, Malek SK, Chandraker AK, Tullius SG, Gabardi S. Transpl Int; 2010 Jun 27; 23(6):636-40. PubMed ID: 20074083 [Abstract] [Full Text] [Related]
13. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, Ko DS, Williams WW, Chandraker A, Delmonico FL, Auchincloss H, Cosimi AB. Transplantation; 2003 Sep 15; 76(5):798-802. PubMed ID: 14501856 [Abstract] [Full Text] [Related]
14. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients. Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L. Liver Transpl; 2004 Mar 15; 10(3):404-7. PubMed ID: 15004768 [Abstract] [Full Text] [Related]
15. Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation. Di Filippo S, Boissonnat P, Sassolas F, Robin J, Ninet J, Champsaur G, Bozio A. Transplantation; 2003 Feb 15; 75(3):354-8. PubMed ID: 12589158 [Abstract] [Full Text] [Related]
16. Effects of intraoperative versus postoperative administration of rabbit antithymocyte antibodies on 1-year renal function in renal transplant patients. Kamar N, Esposito L, Ribes D, Tkaczuk J, Cointault O, Lavayssiere L, Abbal M, Durand D, Rostaing L. Exp Clin Transplant; 2006 Jun 15; 4(1):429-38. PubMed ID: 16827639 [Abstract] [Full Text] [Related]
17. Comparison of clinical outcome of low-dose and high-dose rabbit antithymocyte globulin induction therapy in renal transplantation: a single-center experience. Yang JW, Wang JN, Men TY, Zhang XM, Li XD, Shen B, Li GY, Chen DD. Ann Transplant; 2014 Jun 06; 19():277-82. PubMed ID: 24906405 [Abstract] [Full Text] [Related]
18. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results. Schulz T, Kapischke M, Busing M. Transplant Proc; 2005 May 06; 37(4):1815-7. PubMed ID: 15919475 [Abstract] [Full Text] [Related]
19. Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry. Gaber AO, Matas AJ, Henry ML, Brennan DC, Stevens RB, Kapur S, Ilsley JN, Kistler KD, Cosimi AB, Thymoglobulin Antibody Immunosuppression in Living Donor Recipients Investigators. Transplantation; 2012 Aug 27; 94(4):331-7. PubMed ID: 22850297 [Abstract] [Full Text] [Related]
20. Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety. Esposito L, Kamar N, Durand D, Rostaing L. Transplant Proc; 2005 Mar 27; 37(2):892-4. PubMed ID: 15848567 [Abstract] [Full Text] [Related] Page: [Next] [New Search]